Antimicrobial AApeptides
Antibiotic resistance is one of the biggest public concerns in the 21st century. Host-defense peptides (HDPs) can potentially mitigate the problem through bacterial membrane disruption; however, they suffer from moderate activity and low stability. We recently developed a new class of peptidomimetics termed "AApeptides". This class of peptidomimetics can mimic the mechanism of action of HDPs, and effectively arrest the growth of multidrug resistant Gram-positive and Gram-negative bacteria. As they are built on unnatural backbone, they are resistant to proteolytic degradation. In this review, we summarize the development of this class of antimicrobial peptidomimetics, and discuss the future perspective on how they can move forward on combating antibiotic resistance..
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2017 |
---|---|
Erschienen: |
2017 |
Enthalten in: |
Zur Gesamtaufnahme - volume:17 |
---|---|
Enthalten in: |
Current topics in medicinal chemistry - 17(2017), 11, Seite 1266-1279 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Peng Sang [VerfasserIn] |
---|
Links: |
---|
BKL: |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
OLC1993571582 |
---|
LEADER | 01000caa a2200265 4500 | ||
---|---|---|---|
001 | OLC1993571582 | ||
003 | DE-627 | ||
005 | 20230513222855.0 | ||
007 | tu | ||
008 | 170512s2017 xx ||||| 00| ||eng c | ||
028 | 5 | 2 | |a PQ20170901 |
035 | |a (DE-627)OLC1993571582 | ||
035 | |a (DE-599)GBVOLC1993571582 | ||
035 | |a (PRQ)b1924-fafad9f56790cf9d297bea263483549b2051b98613cb87ff5e1be3cdf4777d50 | ||
035 | |a (KEY)0446467220170000017001101266antimicrobialaapeptides | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 540 |q DE-600 |
084 | |a PHARM |2 fid | ||
084 | |a 44.40 |2 bkl | ||
100 | 0 | |a Peng Sang |e verfasserin |4 aut | |
245 | 1 | 0 | |a Antimicrobial AApeptides |
264 | 1 | |c 2017 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
520 | |a Antibiotic resistance is one of the biggest public concerns in the 21st century. Host-defense peptides (HDPs) can potentially mitigate the problem through bacterial membrane disruption; however, they suffer from moderate activity and low stability. We recently developed a new class of peptidomimetics termed "AApeptides". This class of peptidomimetics can mimic the mechanism of action of HDPs, and effectively arrest the growth of multidrug resistant Gram-positive and Gram-negative bacteria. As they are built on unnatural backbone, they are resistant to proteolytic degradation. In this review, we summarize the development of this class of antimicrobial peptidomimetics, and discuss the future perspective on how they can move forward on combating antibiotic resistance. | ||
700 | 0 | |a Yan Shi |4 oth | |
700 | 0 | |a Peng Teng |4 oth | |
700 | 0 | |a Annie Cao |4 oth | |
700 | 0 | |a Hai Xu |4 oth | |
700 | 0 | |a Qi Li |4 oth | |
700 | 0 | |a Jianfeng Cai |4 oth | |
773 | 0 | 8 | |i Enthalten in |t Current topics in medicinal chemistry |d Hilversum [u.a.] : Bentham Science Publ., 2001 |g 17(2017), 11, Seite 1266-1279 |w (DE-627)338770283 |w (DE-600)2064823-6 |w (DE-576)435515160 |x 1568-0266 |7 nnns |
773 | 1 | 8 | |g volume:17 |g year:2017 |g number:11 |g pages:1266-1279 |
856 | 4 | 2 | |u http://www.eurekaselect.com/openurl/content.php?genre=article&issn=1568-0266&volume=17&issue=11&spage=1266 |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_OLC | ||
912 | |a FID-PHARM | ||
912 | |a SSG-OLC-PHA | ||
912 | |a SSG-OLC-DE-84 | ||
912 | |a SSG-OPC-PHA | ||
912 | |a GBV_ILN_4219 | ||
936 | b | k | |a 44.40 |q AVZ |
951 | |a AR | ||
952 | |d 17 |j 2017 |e 11 |h 1266-1279 |